← Back to Search

Vasodilator

Vascana for Raynaud's Disease

Phase 3
Waitlist Available
Research Sponsored by MediQuest Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon.

Eligible Conditions
  • Raynaud's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Response rate as measured by changes in severity of the Raynaud's symptom most bothersome to the individual patient (Pain, Numbness, or Tingling)
Secondary outcome measures
Changes from baseline in duration of Raynaud's attacks
Changes from baseline in number of Raynaud's attacks
Changes from baseline in overall disease severity measures
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: VascanaActive Control1 Intervention
Group II: VehiclePlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

MediQuest TherapeuticsLead Sponsor
10 Previous Clinical Trials
722 Total Patients Enrolled
Jeff Gregory, MDStudy DirectorMediQuest Therapeutics
3 Previous Clinical Trials
219 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
2009. "Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00934427.
All > Prevention
~6 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top